Clincosm LogoSign in Get a demo

Carcinoma, Non-Small-Cell Lung

Showing NaN - NaN of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Beijing (MRG003)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Apr 7, 2021

NSCLC Trial in Worldwide (Tislelizumab, Concurrent chemoradiotherapy (cCRT), Placebo)

Terminated
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Los Angeles, California
  • +163 more
Jun 26, 2020

NSCLC Trial in Worldwide (Afatinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Beijing, China
  • +32 more
Jun 27, 2019

NSCLC, Docetaxel, Nivolumab Trial in Beijing (Nivolumab)

Unknown status
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jul 16, 2019

NSCLC Trial in Worldwide (afatinib, erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Chandler, Arizona
  • +191 more
Feb 8, 2019

NSCLC Trial in Beijing (Autologous Tcm cells immunotherapy)

Unknown status
  • Carcinoma, Non-Small-Cell Lung
  • Autologous Tcm cells immunotherapy
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Dec 16, 2018

NSCLC, Adenocarcinoma Trial in China, Korea, Republic of, Thailand (Gemcitabine+Cisplatin, BIBW 2992)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Adenocarcinoma
  • Beijing, China
  • +35 more
Dec 13, 2018

NSCLC Trial in Worldwide ( plus docetaxel, BIBF 1120 plus docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • placebo plus docetaxel
  • BIBF 1120 plus docetaxel
  • Graz, Austria
  • +209 more
Nov 9, 2018

NSCLC Trial in Worldwide (Patient Reported Outcomes)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Patient Reported Outcomes
  • Winnipeg, Manitoba, Canada
  • +109 more
Feb 6, 2018

NSCLC Trial in Worldwide (Investigator´s choice of chemo, BIBW 2992)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Investigator´s choice of chemotherapy
  • BIBW 2992
  • Ciudad Autonoma de Buenos Aires, Argentina
  • +97 more
Feb 15, 2017

NSCLC Trial in Worldwide (PF-02341066)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +278 more
Nov 17, 2016

NSCLC Trial in Worldwide (PF-02341066, Pemetrexed, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Little Rock, Arkansas
  • +263 more
Oct 31, 2016

NSCLC Trial in Beijing (Icotinib)

Unknown status
  • Carcinoma, Non-Small-Cell Lung
  • Beijing, China
    Chinese Academy of Medical Sciences
Nov 16, 2016

NSCLC Trial in Worldwide (, BIBW 2992)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • placebo
  • BIBW 2992
  • Kingman, Arizona
  • +89 more
Jun 24, 2016

NSCLC Trial in China (Erlotinib, Chemotherapy)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Beijing, China
  • +10 more
Dec 9, 2015

Circulating Tumor DNA and Tumor Tissue DNA by Targeted

Completed
  • Carcinoma, Non-Small-Cell Lung
    • Beijing, China
      Peking University People's Hospital
    Dec 30, 2015

    NSCLC Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo, Gemcitabine)

    Completed
    Has Results
    • Carcinoma, Non-Small-Cell Lung
    • Sorafenib (Nexavar, BAY43-9006)
    • +3 more
    • Innsbruck, Austria
    • +120 more
    Apr 3, 2015

    NSCLC Trial in Worldwide (Cisplatin, Gemcitabine, PF-3512676)

    Terminated
    • Carcinoma, Non-Small-Cell Lung
    • Birmingham, Alabama
    • +120 more
    Mar 10, 2015

    NSCLC Trial in Worldwide (PF-3512676 + Paclitaxel + Carboplatin, Paclitaxel + Carboplatin)

    Terminated
    • Carcinoma, Non-Small-Cell Lung
    • PF-3512676 + Paclitaxel + Carboplatin
    • Paclitaxel + Carboplatin
    • Little Rock, Alaska
    • +190 more
    Mar 10, 2015

    NSCLC Trial in Worldwide (Sorafenib + Paclitaxel + Carboplatin, Placebo + Paclitaxel + Carboplatin)

    Terminated
    Has Results
    • Carcinoma, Non-Small-Cell Lung
    • Sorafenib + Paclitaxel + Carboplatin
    • Placebo + Paclitaxel + Carboplatin
    • Guangzhou, Guangdong, China
    • +21 more
    Dec 2, 2013

    A Retrospective EGFR Mutation Status Study in Chinese NSCLC

    Unknown status
    • Carcinoma, Non-Small-Cell Lung
      • Beijing, China
        Peking Union Medical College Hospital
      Jun 24, 2011